標(biāo)題: Titlebook: Innovation and Biomedicine; Ethics, Evidence and Mike Michael,Marsha Rosengarten Book 2013 Palgrave Macmillan, a division of Macmillan Publ [打印本頁] 作者: 決絕 時(shí)間: 2025-3-21 17:22
書目名稱Innovation and Biomedicine影響因子(影響力)
書目名稱Innovation and Biomedicine影響因子(影響力)學(xué)科排名
書目名稱Innovation and Biomedicine網(wǎng)絡(luò)公開度
書目名稱Innovation and Biomedicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Innovation and Biomedicine被引頻次
書目名稱Innovation and Biomedicine被引頻次學(xué)科排名
書目名稱Innovation and Biomedicine年度引用
書目名稱Innovation and Biomedicine年度引用學(xué)科排名
書目名稱Innovation and Biomedicine讀者反饋
書目名稱Innovation and Biomedicine讀者反饋學(xué)科排名
作者: 輕信 時(shí)間: 2025-3-21 22:25 作者: 縱火 時(shí)間: 2025-3-22 02:38
en jedoch nicht — wie heute üblich — darauf beschr?nkt sein, als nachfragegesteuerte, passive Informationssysteme mehr oder weniger komfortabel die Informationsnachfragen der Führungskr?fte entgegenzunehmen und das Abfrageergebnis angemessen darzustellen; als aktives Informationssystem sollten sie d作者: 嗎啡 時(shí)間: 2025-3-22 04:42
A Brief and Partial History of Randomized Controlled Trials (RCTs) in the Context of HIV Preventionnd protect participants were not met; and a third group have questioned why the early PrEP trials provoked controversy when, in their view, issues of protecting participants were not so different to other prevention trials. Informing all three positions are some key assumptions that underpin the rat作者: 陶醉 時(shí)間: 2025-3-22 09:35 作者: Jogging 時(shí)間: 2025-3-22 15:43 作者: Vldl379 時(shí)間: 2025-3-22 19:42
Conclusion: Eventuating the Methodology of Trials,rom other sorts of mundane technology which have precipitated novelty (conversely, it is the mirror image of supposedly exotic technologies which simply reproduce or reinforce existing values or functions — see, for example, Michael, 2000; Barry, 2001). So, this book has concerned itself with tracin作者: 小母馬 時(shí)間: 2025-3-22 23:56
sis Related Groups, kurz DRGs genannt, kalkuliert. Das System basiert auf der Idee, medizinisch und ?konomisch gleichwertige Behandlungsf?lle auch gleich zu vergüten. Dazu ermittelt eine begrenzte Anzahl von Krankenh?usern die Fallkosten ihrer Behandlungsf?lle unter Anwendung eines vorgegebenen Kalk作者: CUR 時(shí)間: 2025-3-23 04:00 作者: 發(fā)現(xiàn) 時(shí)間: 2025-3-23 08:54 作者: 窒息 時(shí)間: 2025-3-23 10:40 作者: 反叛者 時(shí)間: 2025-3-23 16:34
A Brief and Partial History of Randomized Controlled Trials (RCTs) in the Context of HIV Preventionntion technologies. These RCTs are mostly prior to pre-exposure prophylactics (PrEP) and the account presented here is meant to contextualize our main object of study, PrEP, and particularly the controversies that surrounded the first round of PrEP RCTs. Central to the story of the early PrEP trials作者: Cupping 時(shí)間: 2025-3-23 18:55 作者: MIR 時(shí)間: 2025-3-24 01:50
The Gold Standard: The Complex Singularity of PrEP, RCT and Bioethics,nacted as singular? As such, we mean to investigate how each is performed as a unitary object or event. Of course, we shall see that RCTs, the pill and bioethics are contested and we shall trace how they are interpreted in conflicting ways. However, ‘behind’ these interpretations there is a commonly作者: Glutinous 時(shí)間: 2025-3-24 04:56 作者: 責(zé)任 時(shí)間: 2025-3-24 06:59
On Some Topologies of PrEP,the relationship between globalization and localization. In other words, we look at the ways in which the specific emergence and role of abstraction in PrEP RCTs are played out as convolutions or, better, ‘involutions’ of globalizing and localizing processes. By drawing on the idea of involutions, i作者: 巧思 時(shí)間: 2025-3-24 13:35 作者: 采納 時(shí)間: 2025-3-24 17:47 作者: callous 時(shí)間: 2025-3-24 22:01
https://doi.org/10.1057/9781137316677bioethics; ethics; HIV; HIV infection; infection; innovation; medicine; methodology; prevention作者: Extemporize 時(shí)間: 2025-3-25 01:31 作者: Calculus 時(shí)間: 2025-3-25 03:59 作者: 無辜 時(shí)間: 2025-3-25 07:59 作者: babble 時(shí)間: 2025-3-25 12:09
Innovation and Biomedicine978-1-137-31667-7Series ISSN 2946-3386 Series E-ISSN 2946-3378 作者: Asymptomatic 時(shí)間: 2025-3-25 19:32
2946-3386 develops a sustained analysis of the complex, virtual and topological dimensions of the expectations, ethics and evidence that surround the innovation of PrEP.978-1-349-33770-5978-1-137-31667-7Series ISSN 2946-3386 Series E-ISSN 2946-3378 作者: oxidize 時(shí)間: 2025-3-25 22:13 作者: SPER 時(shí)間: 2025-3-26 02:04
Introduction: Setting a Scene,hat passes for biomedical innovation. With the development and arrival of a new drug, technology, procedure or intervention, not only might lives be saved, but they can also be endangered at one and the same time.作者: achlorhydria 時(shí)間: 2025-3-26 04:49 作者: 鎮(zhèn)壓 時(shí)間: 2025-3-26 11:47
IronMesopotamia for therapeutic purposes. The oldest manuscript, the Ebers Papyrus, an Egyptian pharmacopea dating around 1500 B.C., describes two remedies that contained iron. The ancient Hindus (500 B.C.) also used iron therapeutically.作者: Pert敏捷 時(shí)間: 2025-3-26 15:34
0302-9743 ine) project. The invited contributions by internationally recognized experts give a thorough survey of several aspects of parallel database systems. The second part of the volume gives an in-depth overview of the PRISMA system. This system is based on a parallel machine, where the individual proces作者: 夸張 時(shí)間: 2025-3-26 17:05 作者: PIZZA 時(shí)間: 2025-3-27 00:33 作者: Admonish 時(shí)間: 2025-3-27 01:46
https://doi.org/10.1007/978-3-030-28979-9nt, and therefore we propose two delay models which are independent of the underlying communication standard. Furthermore, this paper evaluates the existing PCMA* routing algorithm concerning its performance with varying delays and message loss probabilities by applying the introduced delay models i作者: foliage 時(shí)間: 2025-3-27 08:33
Sandip Mane,Sanjay Kumar the emerging information era, and how this world that comes could benefit from it. The second one focuses on how understanding the human genome can open new ways to go beyond what we can consider “traditional Homo Sapiens capabilities”, with especial implications in the health domain and the new me作者: 充氣女 時(shí)間: 2025-3-27 11:17
Dose Determination and Administration of Bacterial Extracellular Vesicles for In Vivo Preclinical Stparations made from diverse bacterial sources (including sterility testing, total protein concentration, particle concentration, and lipopolysaccharide concentration). We also describe basic methodology for intravenous administration of bEV preparations via tail vein injection in laboratory mice. Th作者: 警告 時(shí)間: 2025-3-27 13:51
Die soziale Absicherung h?uslicher Pflege über Grenzen hinweg – Rechtliche Grauzonen, (Ir-)Regularit?t und Legitimit?tentliche Politik tabuisiert die überlastung pflegender Angeh?riger sowie die Entrechtung der Besch?ftigten und ?privatisiert‘ soziale Sicherungsbedarfe, so dass Geschlechterhierarchien und soziale Ungleichheiten transnational verl?ngert werden.作者: legislate 時(shí)間: 2025-3-27 19:16 作者: 防銹 時(shí)間: 2025-3-27 22:55
Pichet Termsarasab,Thananan Thammongkolchai,Bashar Katirjiand environmentally benign biomass sorbent prepared from easily available agriculture waste is suggested. The obtained adsorbents were prepared by a combination of chemical modification and hydrothermal carbonization process with (NH.).C.O.. It was found that the maximum adsorption capacity of hydro作者: 有發(fā)明天才 時(shí)間: 2025-3-28 05:05
